In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

Background The prevalence and prognostic impact of tricuspid regurgitation (TR) remain
incompletely characterized. Methods The distribution of TR severity was analyzed in …

Background Aortic stenosis is the most common cardiac valve disorder requiring clinical
management. However, there is little evidence on the societal cost of progressive aortic …

Aims The criteria for patients with heart failure (HF) and improved ejection fraction
(HFimpEF) are a baseline left ventricular ejection fraction (LVEF)≤ 40%, a≥ 10‐point …

Aims We sought to analyse the distribution of TR severity and survival in a large cohort of
adults with CIED leads. Methods The distribution of TR severity was analysed in 18,797 …

Aims We assessed for an association between improvements in left ventricular ejection
fraction (LVEF) and future outcomes, including health status, in routine clinical practice …

Aims The latest guidelines recommended to assess the trajectory of left ventricular ejection
fraction (LVEF) in patients with heart failure (HF). However, there is limited data on the …

Background: Individuals with heart failure displaying supra-normal left ventricular ejection
fraction (snLVEF) may exhibit less favorable clinical outcomes in contrast to their …

Background Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with
increased risk of cardiac dysfunction. The pathophysiological mechanisms are poorly …

Background The independent effect of pulmonary hypertension (PHT) severity on mortality
in those with reduced left ventricular ejection fraction (LVEF) is not well known. Objectives …